Member Info for Farris

Interesting to know what Surinder Chahal is working on at the moment.

I presume he’s still working for us indirectly.

Anyone know whether we can sell our lysate through any other large company,apart from Croda.

Anyone see the presentation

Yes hopefully, concern is, still 2 short positions on this stock, do they know something we don’t

Agree with all said, so when will we receive that RNS that says revenue and profit will come in way ahead of forecasts.

Cliostock, totally agree, exciting times ahead for skinbiotherapeutics , will be interesting to see if the 2 retailers come to fruition, having to give up more margins than Stuart would like, perhaps an avenue for acne launch.The large multinational often referred to with regards to Axisbiotix and acne would see us off to the races, and then there’s wound care.

Large multinat

Dust, the acne product should sell very well,exactly the thoughts we all had with the psoriasis launch,another debilitating skin condition, let’s hope it’s done better this time.

It’s no good having a great product, that nobody knows about.

Dunk, I think Stuart said exactly that, probably tablet, followed by gum.

That’s got to be hitting sales, surely, i know not massively, but still!!.

Should have been sorted by now.

Going on Amazon, put in Axisbiotix, same as 2 weeks ago, nothing comes up, is it just me?

It’s 14million market cap for a reason, too much debt.

Could be acne launch, could be wound care news, could be dermatonics update?

Sold out?

Or all stock is with a major who are about to launch?

Can not find axisbiotix on Amazon?

Irishdemon, EGT will probably be about 15-20 in a couple of months time, and then hopefully you will go away.

Irish, what’s your background, you seem to think you know more than the EGT board, are you an investor in this company.

It’s a no brainer ,short term back up to 12-14 added to my spread recently

Ady, this is why skinbiotherapeutics is more of a buy than opti, we have no ingredients to pay for, we pay for no advertising, we just receive 10-20% of sales

Let’s hope opti can do the same with sweet.

Dustbin, yes good work, all positive going forward, makes skinbiotherapeutics a great investment opportunity.

Sophie is no Filtered.